Literature DB >> 10733082

An association between length of stay and co-morbidity in chronic airflow limitation.

A J Crockett1, J M Cranston, J R Moss, J H Alpers.   

Abstract

OBJECTIVE: To examine factors which impact on the length of stay and readmission for patients with chronic airflow limitation at a South Australian hospital from December 1996 until March 1998.
DESIGN: Discharges from Flinders Medical Centre for patients aged > or = 18 years, where chronic airflow limitation was an active problem, and including a subset with a primary diagnosis of chronic airflow limitation, were identified, retrospectively, by the center's Clinical Coding Service from the hospital's in-patient separation database.
SETTING: Flinders Medical Centre, Adelaide, South Australia. OUTCOME MEASURES: Length of stay; number of co-morbidities; readmission within 28 days.
RESULTS: Five-hundred and twenty discharges (male:female, 258:262) with a primary diagnosis of chronic airflow limitation (ANDRG-3 177, chronic obstructive airways disease) were identified. Readmission within 28 days was related to the number of co-morbidities and to age. A relationship between length of stay and the number of co-morbidities was identified. A mean length of stay of 6.39 days was found for patients with less than five co-morbidities, 5.36 at their first admission to Flinders Medical Centre and 3.25 at their first admission to Flinders Medical Centre with no co-morbidities. These mean lengths of stay fall below overseas data previously published and are consistent with Kong's estimate of an ideal mean length of stay of 3.2 days when a clinical management guideline is used in low-risk chronic airflow limitation patients.
CONCLUSIONS: Length of stay and readmission to hospital within 28 days of patients with a primary diagnosis of chronic airflow limitation is at least partly related to the number of co-morbidities and to age. The study has highlighted the difficulty of relying on changes to aggregate data as outcome measures for these patients.

Entities:  

Mesh:

Year:  2000        PMID: 10733082     DOI: 10.1093/intqhc/12.1.41

Source DB:  PubMed          Journal:  Int J Qual Health Care        ISSN: 1353-4505            Impact factor:   2.038


  7 in total

Review 1.  An economic overview of chronic obstructive pulmonary disease.

Authors:  H S Ruchlin; E J Dasbach
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 2.  Development of a self-treatment approach for patients with COPD and comorbidities: an ongoing learning process.

Authors:  Tanja W Effing; Anke Lenferink; Julie Buckman; Deborah Spicer; Paul A Cafarella; Morton G Burt; Katherine L Bassett; Clara van Ommeren; Sally Anesbury; Paul D L P M van der Valk; Peter A Frith; Job van der Palen
Journal:  J Thorac Dis       Date:  2014-11       Impact factor: 2.895

3.  Effectiveness and cost-effectiveness of early assisted discharge for chronic obstructive pulmonary disease exacerbations: the design of a randomised controlled trial.

Authors:  Cecile M A Utens; Lucas M A Goossens; Frank W J M Smeenk; Onno C P van Schayck; Walter van Litsenburg; Annet Janssen; Monique van Vliet; Wiel Seezink; Dirk R A J Demunck; Brigitte van de Pas; Peter J de Bruijn; Anouschka van der Pouw; Jeroen M A M Retera; Petra de Laat-Bierings; Loes van Eijsden; Maria Braken; Riet Eijsermans; Maureen P M H Rutten-van Mölken
Journal:  BMC Public Health       Date:  2010-10-18       Impact factor: 3.295

4.  Randomised controlled trial of home based care of patients with chronic obstructive pulmonary disease.

Authors:  Oshana Hermiz; Elizabeth Comino; Guy Marks; Kathy Daffurn; Stephen Wilson; Mark Harris
Journal:  BMJ       Date:  2002-10-26

5.  Length of stay of COPD hospital admissions between 2006 and 2010: a retrospective longitudinal study.

Authors:  Timothy H Harries; Hannah V Thornton; Siobhan Crichton; Peter Schofield; Alexander Gilkes; Patrick T White
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-03-18

6.  The predictive value of an adjusted COPD assessment test score on the risk of respiratory-related hospitalizations in severe COPD patients.

Authors:  Joanne M Sloots; Christopher A Barton; Julie Buckman; Katherine L Bassett; Job van der Palen; Peter A Frith; Tanja W Effing
Journal:  Chron Respir Dis       Date:  2017-02-24       Impact factor: 2.444

7.  [Spontaneous pneumomediastinum: descriptive study of our experience with 36 cases].

Authors:  A Campillo-Soto; A Coll-Salinas; V Soria-Aledo; A Blanco-Barrio; B Flores-Pastor; M Candel-Arenas; J L Aguayo-Albasini
Journal:  Arch Bronconeumol       Date:  2005-09       Impact factor: 4.872

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.